Search

Renowned cancer biologist Joan Massagué, PhD, has been named Director of the Sloan Kettering Institute, one of the most dynamic and robust cancer research programs in the United States, and the research arm of Memorial Sloan Kettering Cancer Center.

… Monday, November 25, 2013 Renowned cancer biologist Joan Massagué, PhD , has been named Director of the Sloan Kettering Institute , one of the most dynamic and robust cancer research programs in the United States, and the research arm of Memorial Sloan Kettering Cancer Center. Dr. Massagué, Chair of

There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer. New data from an observational study published in the October 14 issue of the Journal of the American Medical Association, a theme issue on surgical care, found that breast-conserving surgery was presented and provided in the majority of patients evaluated.

… Tuesday, October 13, 2009 Breast-Conserving Surgery Offered to the Majority of Patients There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer . New data from an observational

A new study by investigators at Memorial Sloan Kettering Cancer Center (MSK) found no evidence of an increased risk of biochemical recurrence with any PDE5 inhibitor use or duration in the first year following radical prostatectomy.

… Tuesday, March 5, 2024 There have been conflicting studies on whether phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil or tadalafil, are associated with an increased risk of biochemical recurrence after radical prostatectomy for prostate cancer. A new study by investigators at Memorial

An MSK geriatrician discusses the importance of helping older people with cancer manage their treatment and symptoms.

… Tuesday, July 9, 2019 Summary Older people with cancer are especially vulnerable to health setbacks during and after treatment. MSK geriatrician Armin Shahrokni explains how monitoring symptoms closely can reduce the risk of serious problems that require a hospital stay. Memorial Sloan Kettering geriatrician

The New York Yankees and Memorial Sloan Kettering Cancer Center have announced a new and unprecedented initiative to raise funds to help support research and treatment for children with cancer.

… Monday, April 10, 2006 Proceeds Aimed at Making a World of Difference to Children with Cancer The New York Yankees and Memorial Sloan Kettering Cancer Center have announced a new and unprecedented initiative to raise funds to help support research and treatment for children with cancer. Memorial Sloan

Learn why a new finding suggests that men with advanced prostate cancer should be screened for gene mutations.

… Wednesday, July 6, 2016 Summary Inherited mutations in DNA-repair genes, such as the BRCA genes , can increase cancer risk. A new study shows that DNA-repair mutations are significantly more common in men with metastatic prostate cancer compared with men whose prostate cancer hasn’t spread. This suggests

Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.

… Tuesday, December 11, 2012 Summary Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients. On December 10, John B. Gurdon of the University of Cambridge and Shinya

Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated.

… Wednesday, July 2, 2014 Summary Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated. Every person’s cancer develops and grows in its own way and is unique in

In honor of Women's History Month, meet the scientific hero who helped build MSK's molecular biology program.

… Wednesday, March 13, 2019 Ora Rosen Ora Rosen, an expert in insulin signaling, co-founded the Molecular Biology Program at the Sloan Kettering Institute. Ora Rosen Dr. Rosen (right) with graduate students Roman Herrera and Lilli Petruzzelli Summary In honor of Women’s History Month, we’re remembering

Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after the disease becomes resistant to standard treatments.

… Tuesday, December 1, 2009 Summary Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after the disease becomes resistant to standard treatments. Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after